Streetbeat News

Price Targets

SKWD

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Skyward Specialty (NASDAQ:SKWD) and raises the price target from $32 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:18 pm

JRVR

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on James River Gr Hldgs (NASDAQ:JRVR) but lowers the price target from $32 to $30.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:17 pm

HIPO

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Hippo Holdings (NYSE:HIPO) but has lowered the price target from $50 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:15 pm

DOMA

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Doma Holdings (NYSE:DOMA) but has lowered the price target from $50 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:11 pm

TSXV:DV

Raymond James analyst Craig Stanley has initiated coverage on Dolly Varden Silver (TSXV:DV) with an Outperform rating and a price target of C$1.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:11 pm

ACGL

JMP Securities analyst Matthew Carletti maintains a Market Outperform rating on Arch Capital Group (NASDAQ:ACGL) and raises the price target from $90 to $95.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:08 pm

SGH

Stifel analyst Jonathan Atkin has maintained a 'Buy' rating on SMART Global Holdings (NASDAQ:SGH), but lowered the price target from $32 to $26.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:03 pm

OM

Stifel analyst Rick Wise has maintained a 'Buy' rating on Outset Medical (NASDAQ:OM) but lowered the price target from $26 to $6.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 1:00 pm

OKE

Mizuho analyst Gabriel Moreen maintains a Neutral rating on ONEOK (NYSE:OKE) and raises the price target from $70 to $72.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:56 pm

HCP

Stifel analyst Brad Reback maintains a Buy rating on HashiCorp (NASDAQ:HCP) but lowers the price target from $32 to $29.

Portfolio Pulse from Benzinga Newsdesk

October 13, 2023 | 12:56 pm